OraSure Preps October Launch Of First-Ever In-Home HIV Test
This article was originally published in The Gray Sheet
Executive Summary
Firm gains PMA approval for OraQuick July 3, making it the first available HIV test that can be performed entirely in the home by untrained users.
You may also be interested in...
OTC Tests For Flu, Strep, STIs Up For Discussion At FDA Panel Meeting
Panelists will look at the benefits and risks of over-the-counter diagnostics for influenza, strep throat and sexually transmitted infections. The meeting is being held in response to sponsor queries about new test designs.
FDA Panel To Ponder Approval Factors For OTC Infectious Disease Diagnostics
FDA plans to hold an advisory panel meeting in mid-August to discuss the potential risks and benefits of clearing or approving over-the-counter infectious disease tests.
New Products In Brief
Debuts include DexCom’s G4 Platinum continuous glucose monitor, OraSure’s OraQuick in-home HIV test and St. Jude’s MediGuide 3D navigation system for cardiovascular procedures.